XSHE
300430
Market cap183mUSD
Jul 10, Last price
4.66CNY
1D
2.42%
1Q
-74.04%
Jan 2017
-76.70%
IPO
-40.26%
Name
Beijing Chieftain Cntrl Engg Tech Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Beijing Chieftain Control Engineering Technology Co., Ltd. (BCCET), established in Beijing, China in 2003, specializes in the development, manufacturing, and sales of advanced automation systems for industrial production processes. The company primarily caters to the biological and pharmaceutical sectors within China. BCCET offers an extensive range of equipment, notably for powder processing, which includes dust-free crushing and pulse air mixing systems, automated lifting hopper mixers, dust-free feeding stations, ton bag unloaders, vacuum conveying solutions, precise metering and packing machines, CIP cleaning units, and auxiliary equipment such as dry granulators. Furthermore, their portfolio features sophisticated aseptic isolation technology, encompassing sterile isolation systems for packing and batching, restricted access barriers, negative pressure isolation units for operating environments, and reactor isolation feeding systems. The company also provides gas chloride sterilization apparatus and intelligent packing machinery. Beyond these, BCCET supplies a comprehensive array of specialized pharmaceutical and chemical equipment, covering processes like Chinese medicine extraction, evaporation concentration, purification and separation, fermentation preparation, distillation, and drying. Complementing their machinery, they also produce high-performance components such as diaphragm valves, globe valves, diaphragm globe valves, and other biomedical products, alongside professional medical pumps. These advanced solutions are widely applied across diverse industries, including pharmaceuticals, chemicals, food processing, additive manufacturing, power generation, and other industrial fields.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||